A detailed history of Virtu Financial LLC transactions in Cerus Corp stock. As of the latest transaction made, Virtu Financial LLC holds 21,639 shares of CERS stock, worth $35,704. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,639
Holding current value
$35,704
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$1.52 - $2.03 $32,891 - $43,927
21,639 New
21,639 $33,000
Q4 2023

Feb 26, 2024

BUY
$1.25 - $2.35 $104,413 - $196,297
83,531 New
83,531 $180,000
Q4 2022

Feb 15, 2023

BUY
$3.38 - $4.22 $62,759 - $78,356
18,568 New
18,568 $68,000
Q2 2021

Sep 17, 2021

SELL
$5.35 - $6.35 $467,038 - $554,335
-87,297 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$5.68 - $7.87 $177,329 - $245,701
31,220 Added 55.67%
87,297 $525,000
Q4 2020

Feb 24, 2021

BUY
$5.25 - $8.56 $294,404 - $480,019
56,077 New
56,077 $388,000
Q3 2020

Dec 11, 2020

SELL
$5.78 - $7.47 $83,630 - $108,083
-14,469 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$4.5 - $7.02 $16,722 - $26,086
-3,716 Reduced 20.43%
14,469 $95,000
Q4 2019

Feb 04, 2020

BUY
$3.84 - $4.86 $69,830 - $88,379
18,185 New
18,185 $77,000
Q2 2019

Aug 13, 2019

SELL
$4.51 - $6.6 $57,001 - $83,417
-12,639 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$5.16 - $6.85 $9,277 - $12,316
1,798 Added 16.59%
12,639 $79,000
Q4 2018

Jan 16, 2019

SELL
$4.89 - $7.16 $14,635 - $21,429
-2,993 Reduced 21.64%
10,841 $55,000
Q3 2018

Nov 13, 2018

BUY
$6.89 - $7.78 $95,316 - $107,628
13,834 New
13,834 $100,000
Q2 2018

Jul 30, 2018

SELL
$5.19 - $7.25 $79,240 - $110,693
-15,268 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$5.19 - $7.25 $79,240 - $110,693
15,268 New
15,268 $102,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $292M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.